University of California, Santa Barbara |
Beth Pruitt |
Conference II |
BIC 2022 - 22nd Annual UC Systemwide Symposium on BioEngineering and Biotechnology Industry Showcase at UCSB |
$50,000 |
BioEclipse Therapeutics INC. |
Pamela Contag |
Clinical Trial Stage Projects |
PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS |
$7,999,689 |
University of California, Davis |
Peter Belafsky |
Clinical Trial Stage Projects |
A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia |
$11,015,936 |
Neurona Therapeutics |
Cory Nicholas |
Clinical Trial Stage Projects |
Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy |
$7,999,999 |
International Society for Stem Cell Research |
Jack Mosher |
Conference II |
ISSCR Standards on Stem Cell Research |
$8,985 |
Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic therapy for treating retinitis pigmentosa and other inherited retinal diseases |
$3,999,553 |
University of California, Los Angeles |
Donald Kohn |
Therapeutic Translational Research Projects |
Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension |
$4,751,297 |
University of Southern California |
PREET Chaudhary |
Therapeutic Translational Research Projects |
Next generation affinity-tuned CAR for prostate cancer |
$5,805,144 |
University of California, Davis |
Aijun Wang |
Medical Device Translational Research Projects |
Living Synthetic Vascular Grafts with Renewable Endothelium |
$3,082,579 |
UCSF Benioff Children’s Hospital Oakland |
Ellen Fung |
Conference - Manage The SPARK Annual Meeting |
2022 CIRM SPARK Research Conference |
$80,000 |
University of California, Los Angeles |
Antoni Ribas |
Late Stage Preclinical Projects |
Skin regeneration and wound healing with a topical BRAF inhibitor |
$5,005,126 |
JDRF International |
Jaime Giraldo |
Conference II |
Spring 2021 Beta Cell Replacement Consortium Meeting |
$25,000 |
Int. Soc. for Cell Gene Ther. |
Queenie Jang |
Conference II |
ISCT 2022 San Francisco Annual Meeting
Bench to Bedside to Benefit
Creating Value for Patients through Translational Science |
$50,000 |
Stanford University |
Joseph Wu |
Conference II |
Stanford Drug Discovery Symposium 2022 |
$29,408 |
International Society for Stem Cell Research |
Chris Barry |
Conference II |
ISSCR 2022 Annual Meeting |
$50,000 |
Stanford University |
Rosa Bacchetta |
Clinical Trial Stage Projects |
Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome |
$11,999,179 |
Stanford University |
Sarah Heilshorn |
Quest - Discovery Stage Research Projects |
Injectable, autologous iPSC-based therapy for spinal cord injury |
$789,000 |
University of California, San Francisco |
Julia Carnevale |
Quest - Discovery Stage Research Projects |
Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering |
$1,463,368 |
Scripps Research Institute |
Luke Lairson |
Quest - Discovery Stage Research Projects |
Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs |
$1,554,126 |
University of California, San Francisco |
Julie Saba |
Quest - Discovery Stage Research Projects |
Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy |
$1,463,400 |
University of California, Irvine |
Mathew Blurton-Jones |
Quest - Discovery Stage Research Projects |
Transplantation of genetically corrected iPSC-microglia for the treatment of Sanfilippo Syndrome (MPSIIIA) |
$1,083,379 |
University of California, San Diego |
Eugene Yeo |
Quest - Discovery Stage Research Projects |
RNA-directed therapy for Huntington's disease |
$1,253,110 |
The Stone Research Foundation for Sports Medicine and Arthritis |
Kevin Stone |
Quest - Discovery Stage Research Projects |
A Novel Therapy for Articular Cartilage Autologous Cellular Repair by Paste Grafting |
$1,180,309 |
Scripps Health |
Darryl D’Lima |
Quest - Discovery Stage Research Projects |
Meniscal Repair and Regeneration |
$1,361,775 |
University of California, Los Angeles |
Song Li |
Quest - Discovery Stage Research Projects |
iPSC Extracellular Vesicles for Diabetes Therapy |
$1,354,928 |
University of California, San Francisco |
Brian Feeley |
Quest - Discovery Stage Research Projects |
Matrix Assisted Cell Transplantation of Promyogenic Fibroadipogenic Progenitor (FAP) Stem Cells |
$1,179,478 |
Stanford University |
Bertha Chen |
Quest - Discovery Stage Research Projects |
iPSC-derived smooth muscle cell progenitor conditioned medium for treatment of pelvic organ prolapse |
$1,420,200 |
Stanford University |
Ansuman Satpathy |
Quest - Discovery Stage Research Projects |
Preclinical development of an exhaustion-resistant CAR-T stem cell for cancer immunotherapy |
$1,420,200 |
Salk Institute for Biological Studies |
Ronald Evans |
Quest - Discovery Stage Research Projects |
Extending Immune-Evasive Human Islet-Like Organoids (HILOs) Survival and Function as a Cure for T1D |
$1,523,285 |
Cytonus Therapeutics, Inc. |
Edward Filardo |
Quest - Discovery Stage Research Projects |
Development of a novel stem-cell based carrier for intravenous delivery of oncolytic viruses |
$899,342 |
Cedars-Sinai Medical Center |
Eduardo Marban |
Quest - Discovery Stage Research Projects |
New noncoding RNA chemical entity for heart failure with preserved ejection fraction. |
$1,397,412 |
Intact Therapeutics, Inc. |
Jeffrey Linhardt |
Quest - Discovery Stage Research Projects |
Modulation of oral epithelium stem cells by RSpo1 for the prevention and treatment of oral mucositis |
$942,050 |
Navega Therapeutics |
Ana Moreno |
Quest - Discovery Stage Research Projects |
Optimization of a gene therapy for inherited erythromelalgia in iPSC-derived neurons |
$1,157,313 |
Cedars-Sinai Medical Center |
Wafa Tawackoli |
SPARK |
Mentored High School Summer Research Program |
$508,750 |
UCSF Benioff Children’s Hospital Oakland |
Ellen Fung |
SPARK |
Supporting Underrepresented STudents Adapting to Change: Summer Program to Accelerate Regenerative Medicine Knowledge (SUSTAIN a SPARK) |
$255,750 |
City of Hope, Beckman Research Institute |
David Ann |
SPARK |
Train, Educate, and Accelerate Mastery of Stem cell research (TEAMS) program |
$508,750 |
Sanford Burnham Prebys Medical Discovery Institute |
Paula Checchi |
SPARK |
Stem Cells & STEM Education - a Summer Internship Program for California High School Students |
$509,000 |
University of California, San Diego |
James Murphy |
SPARK |
Summer Program To Accelerate Regenerative Medicine Knowledge (SPARK) |
$506,712 |
Children's Hospital of Los Angeles |
Mark Frey |
SPARK |
Stem Cell and Regenerative Medicine Summer Internships for High School Students from Under-Served Communities |
$508,750 |
Charles R. Drew University of Medicine and Science |
Dolores Caffey-Fleming |
SPARK |
Exposing Students to Regenerative Medicine (ExStRM) |
$499,500 |
University of California, Davis |
Gerhard Bauer |
SPARK |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$508,750 |
Stanford University |
Paul Utz |
SPARK |
Stem Cell and Regenerative Medicine- High School Summer Research Internship |
$508,750 |
University of California, San Francisco |
Katherine Nielsen |
SPARK |
Stem Cell Summer Research Experiences |
$508,750 |
The Regents of the University of California on behalf of its Riverside Campus |
Huinan Liu |
SPARK |
Summer Training and Research Inspiration for Diverse Pipeline Engagement toward Advancing Stem Cell Treatment (STRIDE) |
$509,000 |
California State University San Marcos Corporation |
James Jancovich |
Conference - Manage The Bridges Annual Meeting |
The 2022 Bridges Annual Meeting |
$137,297 |
Regencor, Inc. |
PILAR RUIZ-LOZANO |
Therapeutic Translational Research Projects |
IND-enabling Studies of Wearable Evolve-FSTL1 for Cardiac Regeneration after MI |
$3,923,191 |
Immusoft Corporation |
Robert Hayes |
Therapeutic Translational Research Projects |
MPS II: Plasma cell delivery of iduronate sulfatase |
$3,994,676 |
University of California, San Diego |
Ezra Cohen |
Late Stage Preclinical Projects |
Late Stage Pre-Clinical Development of a Cirmtuzumab Based CAR T-cell for the Treatment of ROR1+ Hematological Malignancies |
$4,130,260 |
Juvena Therapeutics Inc |
Jeremy O'Connell |
Therapeutic Translational Research Projects |
Clinical Translation of hESC-derived protein therapy that positively regulates the regenerative capacity of post-natal muscle for treating DM1 |
$3,906,376 |
MyoGene Bio LLC |
Courtney Young |
Therapeutic Translational Research Projects |
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy |
$3,400,000 |
University of California, Los Angeles |
Irene Llorente |
Therapeutic Translational Research Projects |
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
$5,925,602 |
University of California, Los Angeles |
Arjun Deb |
Therapeutic Translational Research Projects |
Targeting stromal progenitors to prevent the development of heart failure |
$4,841,428 |
University of California, San Francisco |
Arun Wiita |
Therapeutic Translational Research Projects |
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia |
$3,330,801 |
ImmunoVec |
Katelyn Masiuk |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome |
$3,551,332 |
University of California, Irvine |
Aileen Anderson |
Therapeutic Translational Research Projects |
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury |
$4,950,024 |
University of California, San Francisco |
Hideho Okada |
Therapeutic Translational Research Projects |
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma |
$4,556,536 |
Organos Inc. |
Samuel Wall |
Tool Translational Research Projects |
Human iPSC-derived micro-heart muscles for high-throughput cardiac drug discovery |
$1,119,382 |
University of California, Irvine |
Olga Razorenova |
Conference II |
UCI Stem Cell Research Center 9th Annual Stem Cell Science Symposium |
$8,366 |
Biomedical Engineering Society |
Ryan Green |
Conference II |
2022 BMES-CMBE Annual Meeting: "Lighting and Leading the Way: Molecular Tools in Multicellular Systems” |
$15,000 |
University of Southern California |
Frank Petrigliano |
Late Stage Preclinical Projects |
Plurocart: a novel stem cell-based implant for articular cartilage restoration |
$5,999,782 |
University of California, Davis |
Jan Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$4,966,300 |
Children's Hospital of Los Angeles |
Ching-Ling Lien |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$4,999,500 |
University of California, San Diego |
Alysson Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$4,992,446 |
Scripps Research Institute |
Peter Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$4,931,353 |
University of California, San Francisco |
Robert Blelloch |
Research Training Grant |
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research |
$5,000,000 |
Sanford Burnham Prebys Medical Discovery Institute |
Evan Snyder |
Research Training Grant |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$4,915,671 |
Stanford University |
Maria Grazia Roncarolo |
Clinical Trial Stage Projects |
Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. |
$10,563,822 |
University of California, Santa Barbara |
Dennis Clegg |
Research Training Grant |
CIRM Training Program in Stem Cell Biology and Engineering |
$1,924,497 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$4,999,333 |
University of California, Irvine |
Peter Donovan |
Research Training Grant |
CIRM Scholars Comprehensive Research Training Program |
$5,000,000 |
The Regents of the University of California on behalf of its Riverside Campus |
Prudence Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$4,993,115 |
Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center |
Virender Rehan |
Research Training Grant |
Stem Cell Training Program at the Lundquist Institute |
$4,975,367 |
University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,000,000 |
University of Southern California |
Gage DeKoeyer Crump |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,000,000 |
University of California, Santa Cruz |
Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$4,913,271 |
Gladstone Institutes, J. David |
Bruce Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,000,000 |
City of Hope, Beckman Research Institute |
Michael Barish |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$4,860,989 |
Stanford University |
Tushar Desai |
Research Training Grant |
CIRM Scholar Training Program |
$4,974,073 |
University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$4,954,238 |
University of California, Davis |
David Segal |
Quest - Discovery Stage Research Projects |
AAV9-Cas13 gene therapy for Angelman syndrome |
$1,364,903 |
Stanford University |
Marius Wernig |
Quest - Discovery Stage Research Projects |
A universally applicable skin sheet for Dystrophic Epidermolysis Bullosa via next-generation gene editing, iPS cell technology and tissue engineering |
$1,229,040 |
University of California, San Diego |
Dan Kaufman |
Quest - Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor expressing macrophages for improved cancer treatment. |
$1,256,332 |
University of California, San Diego |
Ziwei Huang |
Quest - Discovery Stage Research Projects |
Development of a new therapeutic for directing target specific stem cell migration and treatment |
$1,129,512 |
Stanford University |
Stanley Qi |
Quest - Discovery Stage Research Projects |
A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering |
$704,661 |
Stanford University |
Gary Steinberg |
Clinical Trial Stage Projects |
Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke |
$11,998,988 |
Stanford University |
Crystal Mackall |
Clinical Trial Stage Projects |
Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma |
$11,998,310 |
Stanford University |
Joseph Wu |
Clinical Trial Stage Projects |
A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR) |
$6,987,507 |
University of California, Davis |
Deborah Lieu |
Quest - Discovery Stage Research Projects |
Building a hiPSC-based biopacemaker |
$1,260,827 |
University of California, San Diego |
Tannishtha Reya |
Quest - Discovery Stage Research Projects |
Targeting Critical Regulators of Cancer Stem Cells |
$1,148,264 |
University of California, San Francisco |
Marisa Medina |
Quest - Discovery Stage Research Projects |
iPSCs as a screening tool to predict risk of nonalcoholic fatty liver disease |
$813,000 |
University of California, Irvine |
Munjal Acharya |
Quest - Discovery Stage Research Projects |
Stem cell-derived extracellular vesicles to reverse radiation-induced brain injury |
$1,064,724 |
Stanford University |
Kathleen Sakamoto |
Quest - Discovery Stage Research Projects |
Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia |
$848,098 |
Stanford University |
Phillip Yang |
Quest - Discovery Stage Research Projects |
Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair |
$1,418,023 |
SJSU Research Foundation |
Tzvia Abramson |
Bridges |
Stem Cell Internships in Laboratory-based Learning ( SCILL) continue to expand the scientific workforce for stem cells research and therapies . |
$3,606,500 |
Cal State Univ, Sacramento |
Kimberly Mulligan |
Bridges |
Strengthening the Pipeline of Master's-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,946,500 |
San Francisco State University |
Lily Chen |
Bridges |
CIRM Bridges Science Master’s Program |
$3,606,500 |
California State University, Channel Islands |
Nitika Parmar |
Bridges |
CIRM Graduate Student Training in Stem Cell Sciences in the Stem Cell Technology and Lab Management Emphasis of the MS Biotechnology Program |
$3,558,692 |
The University Corporation at California State University, Northridge |
Cindy Malone |
Bridges |
CSUN CIRM Bridges3.0 Stem Cell Research & Therapy Training Program |
$3,606,500 |
Cal State Univ, San Bernadino |
Nicole Bournias-Vardiabasis |
Bridges |
Stem Cell Scholars: a workforce development pipeline, educating, training and engaging students from basic research to clinical translation. |
$3,606,500 |
University of California, San Francisco |
Mark Walters |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |